NIAGEN BIOSCIENCE INC (NAGE) Stock Analyst Earnings Estimates
NASDAQ:NAGE - Nasdaq - US1710774076 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 72.05M 6.82% | 83.57M 15.99% | 99.597M 19.18% | 125.93M 26.44% | 151.19M 20.06% | 180.94M 19.68% | |
| EBITDA YoY % growth | -17.57M 32.29% | -4.571M 73.98% | 8.54M 286.83% | 13.304M 55.78% | 22.179M 66.71% | 32.844M 48.09% | |
| EBIT YoY % growth | -18.63M 31.18% | -5.599M 69.95% | 7.726M 237.99% | 9.447M 22.28% | 17.621M 86.52% | 24.077M 36.64% | |
| Operating Margin | -25.86% | -6.70% | 7.76% | 7.50% | 11.65% | 13.31% | |
| EPS YoY % growth | -0.26 36.59% | -0.07 73.08% | 0.10 242.86% | 0.13 32.60% | 0.24 84.62% | 0.37 52.08% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.02 2.00% | 0.03 -63.73% | 0.07 19.00% | 0.04 -10.75% | 0.05 150.00% | 0.06 71.88% |
| Revenue Q2Q % growth | 31.319M 22.44% | 34.625M 18.88% | 37.244M 22.19% | 33.048M 6.20% | 35.955M 14.80% | 37.128M 7.23% |
| EBITDA Q2Q % growth | 2.536M 13.88% | 3.338M -57.88% | 6.722M 35.33% | 4.636M 133.91% | 5.707M 125.04% | 6.202M 85.80% |
| EBIT Q2Q % growth | 1.391M -13.17% | 2.276M -67.99% | 4.962M 3.98% | 2.764M 120.41% | 4.06M 191.88% | 4.32M 89.81% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.04 | 0.01 | 0.03 | 180.11% |
| Q1 2025 Q2Q % growth | 0.06 700.00% | 0.02 | 0.04 | 252.87% |
| Q4 2024 Q2Q % growth | 0.09 | 0.02 | 0.07 | 341.18% |
| Q3 2024 Q2Q % growth | 0.02 300.00% | 0.00 | 0.02 | 488.82% |
| Q2 2024 Q2Q % growth | 0.00 100.00% | -0.02 | 0.02 | 100.00% |
| Q1 2024 Q2Q % growth | -0.01 66.67% | -0.02 | 0.01 | 41.19% |
| Q4 2023 Q2Q % growth | 0.00 100.00% | -0.03 | 0.03 | 100.00% |
| Q3 2023 Q2Q % growth | -0.01 75.00% | -0.03 | 0.02 | 69.83% |
| Q2 2023 Q2Q % growth | -0.03 66.67% | -0.04 | 0.01 | 21.57% |
| Q1 2023 Q2Q % growth | -0.03 72.73% | -0.05 | 0.02 | 38.73% |
| Q4 2022 Q2Q % growth | -0.02 75.00% | -0.02 | 0.00 | 18.88% |
| Q3 2022 Q2Q % growth | -0.04 69.23% | -0.06 | 0.02 | 36.75% |
| Q2 2022 Q2Q % growth | -0.09 -12.50% | -0.09 | 0.00 | -3.81% |
| Q1 2022 Q2Q % growth | -0.11 8.33% | -0.09 | -0.02 | -17.22% |
| Q4 2021 Q2Q % growth | -0.08 20.00% | -0.10 | 0.02 | 21.57% |
| Q3 2021 Q2Q % growth | -0.13 -85.71% | -0.09 | -0.04 | -38.53% |
| Q2 2021 Q2Q % growth | -0.08 -33.33% | -0.08 | 0.00 | 4.35% |
| Q1 2021 Q2Q % growth | -0.12 -20.00% | -0.09 | -0.03 | -36.80% |
| Q4 2020 Q2Q % growth | -0.10 33.33% | -0.10 | 0.00 | -3.20% |
| Q3 2020 Q2Q % growth | -0.07 41.67% | -0.10 | 0.03 | 29.97% |
| Q2 2020 Q2Q % growth | -0.06 53.85% | -0.11 | 0.05 | 43.98% |
| Q1 2020 Q2Q % growth | -0.10 33.33% | -0.11 | 0.01 | 12.85% |
| Q4 2019 Q2Q % growth | -0.15 | -0.11 | -0.04 | -30.72% |
| Q3 2019 Q2Q % growth | -0.12 | -0.12 | 0.00 | -0.84% |
| Q2 2019 Q2Q % growth | -0.13 | -0.14 | 0.01 | 4.41% |
| Q1 2019 Q2Q % growth | -0.15 | -0.12 | -0.03 | -26.05% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 31.12M 36.86% | 28.89M | 2.23M | 7.72% |
| Q1 2025 Q2Q % growth | 30.481M 37.59% | 27.642M | 2.839M | 10.27% |
| Q4 2024 Q2Q % growth | 29.125M 37.41% | 27.268M | 1.857M | 6.81% |
| Q3 2024 Q2Q % growth | 25.58M 31.18% | 24.116M | 1.464M | 6.07% |
| Q2 2024 Q2Q % growth | 22.739M 11.90% | 23.905M | -1.166M | -4.88% |
| Q1 2024 Q2Q % growth | 22.153M -1.80% | 24.449M | -2.296M | -9.39% |
| Q4 2023 Q2Q % growth | 21.196M 0.93% | 21.403M | -207K | -0.97% |
| Q3 2023 Q2Q % growth | 19.5M 14.30% | 20.654M | -1.154M | -5.59% |
| Q2 2023 Q2Q % growth | 20.32M 21.46% | 19.572M | 748K | 3.82% |
| Q1 2023 Q2Q % growth | 22.56M 30.71% | 19.708M | 2.852M | 14.47% |
| Q4 2022 Q2Q % growth | 21M 18.24% | 21.559M | -559K | -2.59% |
| Q3 2022 Q2Q % growth | 17.06M -1.44% | 19.061M | -2.001M | -10.50% |
| Q2 2022 Q2Q % growth | 16.73M -5.48% | 19.019M | -2.289M | -12.04% |
| Q1 2022 Q2Q % growth | 17.26M 17.57% | 17.573M | -313K | -1.78% |
| Q4 2021 Q2Q % growth | 17.76M 14.95% | 18.94M | -1.18M | -6.23% |
| Q3 2021 Q2Q % growth | 17.31M 22.07% | 17.519M | -209K | -1.19% |
| Q2 2021 Q2Q % growth | 17.7M 15.76% | 17.501M | 199K | 1.14% |
| Q1 2021 Q2Q % growth | 14.68M 2.30% | 17.015M | -2.335M | -13.72% |
| Q4 2020 Q2Q % growth | 15.45M 18.03% | 15.671M | -221K | -1.41% |
| Q3 2020 Q2Q % growth | 14.18M 17.68% | 14.579M | -399K | -2.74% |
| Q2 2020 Q2Q % growth | 15.29M 37.75% | 14.148M | 1.142M | 8.07% |
| Q1 2020 Q2Q % growth | 14.35M 42.79% | 14.035M | 315K | 2.24% |
| Q4 2019 Q2Q % growth | 13.09M | 13.169M | -79K | -0.60% |
| Q3 2019 Q2Q % growth | 12.05M | 11.824M | 226K | 1.91% |
| Q2 2019 Q2Q % growth | 11.1M | 11.029M | 71K | 0.64% |
| Q1 2019 Q2Q % growth | 10.05M | 9.821M | 229K | 2.33% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -39.99% | 0% | 11.43% |
| Revenue | 0% | 0.92% | 0% | 4.04% |